Publications 2004

PUBLICATIONS 2004:

Ambrose, R.N. Jones, J.S. Owen, S. Van Wart, S.M. Bhavnani, M. Piedmont, and J.B. Anon. Use of Pharmacodynamic endpoints in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis. Clinical Infectious Diseases. 2004 38(1):1513-1520.

S.M. Bhavnani, J.S. Owen, J. Loutit, S. Porter, P.G. Ambrose. Safety, tolerability, and pharmacokinetics of ascending single intravenous doses of oritavancin administered to healthy subjects. Diagnostic Microbiology and Infectious Disease, 2004 50(2):95–102.

Van Wart S, Phillips L, Ludwig EA, Russo R, Gajjar DA, Bello A, Ambrose PG, Costanzo C, Grasela TH, Echols R, Grasela DM. Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother. 2004 Dec;48(12):4766-77.

Barie PS, Rotstein OD, Dellinger EP, Grasela TH, Walawander CA. The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection. Surg Infect (Larchmt). 2004 Fall;5(3):269-80.

Owens RC, Ambrose PG, Nightingale CH. Antiobiotic Optimization Through Innovative Programs, Guidelines and Formulary Considerations. New York, Marcel Dekker Publishers, 2004.

Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, Craig WA. Sinus and allergy Health Partnership, Otolaryngology Head Neck Surgery. 2004 January; 130(1 Suppl): 1-45.